Showing results (41-50 of 801) with videos related to
Sort By:
Pageof 81
Blood|February 1, 1987
Epidemiological investigation of the prevalence of von Willebrand's diseaseF Rodeghiero, G Castaman, E DiniActa Haematologica|June 10, 2009
Autosomal recessive von Willebrand disease type 1 or 2 due to homozygous or compound heterozygous mutations in the von Willebrand factor gene. A single center experience on molecular heterogeneity and laboratory features in 12 familiesG Castaman, S Giacomelli, F RodeghieroHaematologica|November 1, 1993
Acquired plasma factor XIII deficienciesA Tosetto, G Castaman, F RodeghieroJournal of Thrombosis and Haemostasis : JTH|July 2, 2013
Bleeders, bleeding rates, and bleeding scoreA Tosetto, G Castaman, F RodeghieroThrombosis Research|January 1, 1990
Fibrinopeptide A changes during remission induction treatment with L-asparaginase in acute lymphoblastic leukemia: evidence for activation of blood coagulationF Rodeghiero, G Castaman, E DiniHamostaseologie|January 20, 2009
Chronic immune thrombocytopenic purpura. New agentsF Rodeghiero, M RuggeriBlood Reviews|September 1, 1991
Clinical indications for desmopressin (DDAVP) in congenital and acquired von Willebrand diseaseF Rodeghiero, G Castaman, P M MannucciThrombosis and Haemostasis|November 1, 1996
Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia AF Rodeghiero, G Castaman, P M MannucciThrombosis and Haemostasis|December 29, 2000
The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and ArteriosclerosisA Tosetto, G Castaman, A Cappellari, et al.Seminars in Thrombosis and Hemostasis|October 1, 1985
A contribution to the pathology of acquired plasma factor XIII deficiencyG Ballerini, S Guerra, F Rodeghiero, et al.Pageof 81